MicroRNAs in Chronic Lymphocytic Leukemia: miRacle or miRage for Prognosis and Targeted Therapies?

Seminars in Oncology - United Kingdom
doi 10.1053/j.seminoncol.2016.02.015
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

P53 and microRNAs in Chronic Lymphocytic Leukemia

Journal of Nucleic Acids Investigation
2011English

Prognosis and New Therapeutic Approaches in Chronic Lymphocytic Leukemia Treatment

Medicinski podmladak
2019English

Reprint Of: A Review of Cellular Therapies for Chronic Lymphocytic Leukemia

Biology of Blood and Marrow Transplantation
TransplantationHematology
2014English

Comparative Analysis of Targeted Novel Therapies in Relapsed, Refractory Chronic Lymphocytic Leukaemia

Haematologica
Hematology
2020English

An Improved Benefit-Risk Profile of Duvelisib in Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Who Received 2 or More Prior Therapies

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Chronic Lymphocytic Leukemia

Current Opinion in Hematology
Hematology
1998English

Chronic Lymphocytic Leukemia

Orvosi Hetilap
Medicine
2008English

Chronic Lymphocytic Leukemia

ASH Image Bank
2003English

Chronic Lymphocytic Leukemia

Molecular and Translational Medicine
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy